The clinical evidence for postbiotics as microbial therapeutics

Area of Science:

• Microbiology
• Immunology
• Metabolic Health

Background:

• A balanced microbiome is crucial for health, but dysbiosis can lead to harmful metabolites.
• Probiotics can help manage microbiome imbalances but have safety and viability concerns, especially in vulnerable populations.
• Postbiotics, inactivated microbial components, are emerging as a stable and effective alternative.

Purpose of the Study:

• To review the clinical evidence supporting postbiotic use in prevalent conditions.
• To explore the potential future applications of postbiotics in healthcare.
• To understand the interaction mechanisms between postbiotics and the host microbiome.

Main Methods:

• Systematic review of existing clinical studies on postbiotics.
• Analysis of postbiotic composition and their associated health benefits.
• Exploration of safety profiles and viability compared to probiotics.

Main Results:

• Growing evidence indicates diverse clinical benefits of postbiotics across various prevalent conditions.
• Postbiotics demonstrate comparable health benefits to probiotics with improved stability and safety.
• Understanding of postbiotic-microbiome interactions is advancing.

Conclusions:

• Postbiotics represent a promising therapeutic strategy for microbiome-related health issues.
• They offer a potentially safer and more stable alternative to live probiotics.
• Further research into interaction mechanisms will enable targeted postbiotic therapies.